Archivio Istituzionale della RicercaAlthough a 1-year duration of dual antiplatelet therapy (DAPT) is used in many patients after drug-eluting stent (DES) implantation, the evidence supporting this duration is uncertain.
Risk-Benefit of 1-Year DAPT After DES Implantation in Patients Stratified by Bleeding and Ischemic Risk / Palmerini, T., Bruno, A.G., Redfors, B., Valgimigli, M., Taglieri, N., Feres, F., Abizaid, A., Costa, R., Gilard, M., Morice, M., Hong, M., Kim, B., Jang, Y., Kim, H., Park, K.W., Colombo, A., Chieffo, A., Nakamura, M., Kotinkaduwa, L.N., Nardi, E., et al.. - In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. - ISSN 1558-3597. - 78:20(2021), pp. 1968-1986. [10.1016/j.jacc.2021.08.070]
Risk-Benefit of 1-Year DAPT After DES Implantation in Patients Stratified by Bleeding and Ischemic Risk
Gasparini, Mauro;
2021
Abstract
Although a 1-year duration of dual antiplatelet therapy (DAPT) is used in many patients after drug-eluting stent (DES) implantation, the evidence supporting this duration is uncertain.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Risk-Benefit of 1-Year DAPT After DES Implantation in Patients Stratified by Bleeding and Ischemic Risk.pdf
accesso riservato
Tipologia:
2a Post-print versione editoriale / Version of Record
Licenza:
Non Pubblico - Accesso privato/ristretto
Dimensione
2.11 MB
Formato
Adobe PDF
|
2.11 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
https://hdl.handle.net/11583/2970080